RegenxBio News and Activities

Presence

RegenxBio is a biotechnology company that develops gene therapies for retinal, neurodegenerative, and rare diseases. Its products and services include therapy candidates, research platforms, and development support for patients, healthcare providers, and biopharma partners.

RegenxBio products and services overview:

  • Gene therapies
  • Drug development
  • Research platforms
  • Rare disease treatments
  • Retinal treatments
  • Partnership services

Revenue: ~$100 million

Employees: 350

Headquarters: Rockville, United States (USA)


RegenxBio is one of the...

RegenxBio is a company listed under the stock ticker RGNX (US).

Executives

View the org chart displaying its 30 main executives

Most searched biographies at RegenxBio

Create your alert
to follow the executive moves at RegenxBio.

Biotechnology

RegenxBio has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry

News

Press releases by RegenxBio
Social media about RegenxBio

Get in Touch

Call RegenxBio at +1 20...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board